Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
inflammaging
Investment
Investment
GlycanAge teams up with Japan on aging science
Investment
Investment
Re-engineering immune memory for tissue repair
Biotech
BioAge advances inflammaging drug into Phase 2
Diagnostics
Ecosystem
New GlycanAge conference pushes inflammaging into care
Biotech
Inflammation’s statin moment edges closer
Biotech
Mesoblast invests in smarter cell therapies with new CAR tech deal
Ecosystem
Supplements
SIRIO Europe rolls out new habit-first longevity platform
Biotech
UK nod for Soligenix drug links rare disease to healthspan
Biotech
Three drugs in major study to prove their capacity to slow aging
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report
